Advertisement
UK markets close in 1 hour 19 minutes
  • FTSE 100

    8,132.59
    +53.73 (+0.67%)
     
  • FTSE 250

    19,825.79
    +223.81 (+1.14%)
     
  • AIM

    755.58
    +2.46 (+0.33%)
     
  • GBP/EUR

    1.1675
    +0.0019 (+0.16%)
     
  • GBP/USD

    1.2498
    -0.0013 (-0.11%)
     
  • Bitcoin GBP

    51,547.41
    +688.89 (+1.35%)
     
  • CMC Crypto 200

    1,338.51
    -58.03 (-4.02%)
     
  • S&P 500

    5,103.28
    +54.86 (+1.09%)
     
  • DOW

    38,294.36
    +208.56 (+0.55%)
     
  • CRUDE OIL

    83.93
    +0.36 (+0.43%)
     
  • GOLD FUTURES

    2,354.60
    +12.10 (+0.52%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,157.05
    +239.77 (+1.34%)
     
  • CAC 40

    8,094.87
    +78.22 (+0.98%)
     

Expert Quantitative Analysis on the COVID-19 Contract Vaccine Manufacturing Industry

Dublin, Jan. 07, 2021 (GLOBE NEWSWIRE) -- The "Coronavirus Disease 2019 (COVID-19) Vaccines - Contract Development and Manufacturing Landscape" report has been added to ResearchAndMarkets.com's offering.

This expert trend report is a comprehensive look at the contract manufacturing landscape surrounding COVID-19 Vaccine in 2020, including analysis of pipeline drugs, clinical trials, CMO activity, Contract Manufacturing Service Agreements, and funding for manufacturing of COVID-19 Vaccines. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.

Scope

  • This report gives an important expert quantitative analysis on the COVID-19 contract vaccine manufacturing industry.

Reasons to Buy

  • What are the pipeline COVID-19 prophylactic vaccines by developer type?

  • What are the top pipeline COVID-19 prophylactic vaccines analyst consensus sales forecast?

  • What is the distribution of COVID-19 prophylactic vaccines clinical trials?

  • What and Where are CMOs vaccine manufacturing facilities?

  • What are the COVID-19 vaccine contract manufacturing service agreements by Molecule Type?

  • What are the COVID-19 vaccine contract manufacturing service agreements by Service?

  • What are the COVID-19 vaccine contract manufacturing service agreements by CMO?

  • What are the COVID-19 vaccine contract manufacturing service agreements by Sponsor?

ADVERTISEMENT

Key Topics Covered:

1 Executive Summary

2 Players

3 Technology Briefing
3.1 What is COVID-19?
3.2 COVID-19 Pipeline Vaccine Types and Technology

4 Trends

5 Industry Analysis
5.1 COVID-19 Pipeline Vaccines
5.2 COVID-19 Vaccine Projected Sales
5.3 Contract Manufacturing Capabilities for Vaccines
5.4 COVID-19 Vaccine Contract Service Agreements
5.5 Investors in COVID-19 Vaccine Manufacturing
5.5.1 Governments
5.5.2 Pharma Companies
5.5.3 CMOs

6 Value Chain

7 Companies

8 Appendix

Companies Mentioned (Partial List)

  • 3T Biosciences Inc.

  • 7 Hills Pharma LLC

  • Abnova Corp.

  • AbVision Inc.

  • Acibadem University

  • Adaptive Phage Therapeutics Inc.

  • Adimmune Corp.

  • Advanced BioScience Laboratories Inc.

  • Advent Srl

  • Aegis Life Inc.

  • AGC Biologics Inc.

For more information about this report visit https://www.researchandmarkets.com/r/40y72f

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900